Abstract | BACKGROUND: Primary focal hyperhidrosis is a common condition that gives rise to functional and emotional problems and may disturb professional and social life. Recently, low-dose intracutaneous injections of botulinum toxin A have been shown to induce a temporary anhidrosis, with relapses occurring usually after 4 to 6 months. OBJECTIVE: DESIGN: SETTINGS: University medical center. PATIENTS: Twenty-four patients with axillary hyperhidrosis were treated. Their ages ranged from 19 to 58 years (mean +/- SD, 34.8 +/- 12.4 years). MAIN OUTCOME MEASURES: Reduction of sweating as assessed by the Minor iodine- starch test and planimetry of hyperhidrotic areas. Patients were interviewed at the end of follow-up about their satisfaction with this treatment. RESULTS: Within 6 days, all patients reported cessation of excessive sweating. The mean +/- SD area of excessive sweating identified by the Minor iodine- starch test decreased from 19.27 +/- 11.95 cm2 to 0.25 +/- 0.61 cm2 (P<.001). The mean follow-up was 10.0 +/- 2.8 months (range, 5-15 months). Four patients (17%) reported a return of axillary hyperhidrosis after 7 to 10 months. All patients who experienced relapse showed an excellent response to a second treatment. The only adverse effects reported were temporary pain and burning during the injections. No muscular weakness, insensitivity, or systemic reactions were observed. CONCLUSIONS:
|
Authors | T Karamfilov, H Konrad, K Karte, U Wollina |
Journal | Archives of dermatology
(Arch Dermatol)
Vol. 136
Issue 4
Pg. 487-90
(Apr 2000)
ISSN: 0003-987X [Print] United States |
PMID | 10768647
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Dermatologic Agents
- Botulinum Toxins, Type A
|
Topics |
- Adult
- Axilla
- Botulinum Toxins, Type A
(administration & dosage, adverse effects)
- Dermatologic Agents
(administration & dosage, adverse effects)
- Dose-Response Relationship, Drug
- Female
- Humans
- Hyperhidrosis
(drug therapy)
- Injections, Intradermal
- Male
- Middle Aged
- Secondary Prevention
- Treatment Outcome
|